International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-5 doi: 10.5281/zenodo.10014303
Original Article
Heart Rate Variability & Behavioral Changes in Normal & Premenstural Syndrome Cases in Follicular and Late Leuteal Phase in Medical Students
 ,
Published
Oct. 16, 2023
Abstract

Background: Premenstrual syndrome (PMS) shows a wide variety of cyclic and recurrent physical, emotional, and behavioral symptoms occurring during the late luteal phase of the menstrual cycle and abating shortly following the beginning of menses. The present study assesses whether the activity of the autonomic nervous system is altered during the menstrual cycle of women with different degrees of premenstrual symptomatology

Material & Methods: Twenty PMS cases with their mean age 20±1.5 with regular menstrual cycles participated in this study. The autonomic nervous system activity was noninvasively measured by HRV power spectral analysis & menstrual distress questionnaire was compared among normal controls & PMS cases.

Results: has shown significant change in VHF (P=0.00), VLF (P=0.02), Sympathetic vagal balance (P=0.05) in PMS cases as compared to control. Significant increase in VHF (P=0.03) & VLF (P=0.00) is seen in leuteal phase as compared to follicular phase in PMS cases. SDNN & RR interval was also compared it was found to be significantly decreased in leuteal phase of PMS cases as compared to controls.

Conclusion: we can say that there is sympathetic over activity in Late leuteal phase  of menstrual cycle in females of age group 20-25.This sympathetic over activity hampers in day to day routines of the subjects as dysphoric symptoms are increased markedly during late luteal phase in PMS cases as compared to controls.

Recommended Articles
Loading Image...
Volume-4, Issue-5
Citations
2583 Views
5 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved